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F R A N C E S C  VILARDELL 
THE RELATIONSHIP BETWEEN DOCTOR AND PATIENT HAS 
ALWAYS BEEN AT THE FOREFRONT OF MEDICAL ETHICS AND THE 
DEBATE HAS GONE ON UNINTERRUPTED ALL THESE YEARS. BUT 
UNQUESTIONABLY, THE MODERN WORLD, WHICH HAS 
UNDERGONE A RADICAL TRANSFORMATION THIS CENTURY, 
CARRIES WITH IT A SERIES OF DEMANDS THAT WEIGH HEAVILY 
ON THE DOCTOR-PATIENT RELATIONSHIP. 
ow 62, Doctor Francesc Vilardell 
Viñas has, since July 1987, been 
president of the Council of Inter- 
national Organizations of Medical Sci- 
ences, CIOMS, created at the beginning 
of the fifties by the WHO and UNESCO, 
to reflect and advise on medical ethics, 
the philosophy of medicine and other 
matters relevant to the profession, 
amongst them the training that doctors 
should receive and the moral obligations 
that should regulate their practice. 
Professor Vilardell is president of the 
World Organization of Gastro-enterolo- 
gy and has received various awards, 
amongst them the French Legion of Ho- 
nour, the Generalitat's Saint George 
Cross and the Spanish Ministry of 
Health's Encomienda al Mérito Sanitario. 
In May 1981 he was called urgently to 
Rome, to join three other specialists 
watching over Pope John Paul 11's recov- 
ery from his assassination attempt. 
Married and father of three children, he 
is devoted to his work as head of the 
Digestive Pathology department of the 
Sant Pau Hospital, in Barcelona. The son 
and nephew of doctors, he was born in 
Barcelona in 1926 and graduated in 
Medicine in 1949. In 1962 he completed 
his specialist studies at the University of 
Pennsylvania (USA), with a doctoral 
thesis on the cytological diagnosis of sto- 
mach cancer. In 1963 he joined the Sant 
Pau hospital, where he continues 
working to this day. He enjoys a stroll in 
the gardens when in need of a moment of 
relaxation, never tiring of the harmoni- 
ous arrangement of Domknech i Mon- 
taner's Modernist pavilions. Professor 
Vilardell has taken over the presidency of 
the CIOMS at a particularly delicate 
moment for the medical profession, 
which today has access to techniques that 
are capable of altering the course of hu- 
man nature in a way which was unthink- 
able just a few decades ago. The sudden 
emergence of these technical possibilities 
poses new ethical problems, but techno- 
logical development takes place so fast 
that society has not even had time to re- 
flect. For this reason, Doctor Vilardell's 
job at the head of the CIOMS involves 
such a great responsability. 
What are the particular aspects of the 
problem posed by medical ethics in to- 
day 'S  society ? 
There's nothing new about medical 
ethics; the earliest references to society's 
concern for this subject date from 5,000 
years B.C. And from then until now, al1 
it's done is to develop. d he relationship 
between doctor and patient has always 
been at the forefront of medical ethics 
and the debate has gone on uninterrup- 
ted al1 these years. But unquestionably, 
the modern world, which has undergone 
a radical transformation this century, 
carries with it a series of demands that 
weigh heavily on the doctor-patient rela- 
tionship. This relationship has been W 
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substantially modified over the last few 
years. One of the most important aspects 
has been the gradual generalization of a 
particular idea, that of the patient's 
autonomy, seen as the right to take part 
in the decisions that affect his health. 
This principle is based on Anglo-Saxon 
law, which defends the autonomy of the 
individual and freedom of choice as es- 
sential elements. 
But freedom of choice and the ability to 
use his autonomy depend, in the patient's 
case, on his receiving accurate infor- 
mation from the doctor. 
Of course. From what's been said, it can 
be deduced that this autonomy can't 
really exist unless there's informed con- 
sent, which means that, before any 
medical intervention, especially if it 
involves a risk, the patient has to be suffi- 
ciently informed so as to be able to de- 
cide whether or not he accepts the risk to 
which he is being submitted. This calls 
for a willingness, on the part of the doc- 
tor, to keep the patient informed. The 
problem is easier to solve in more ad- 
vanced cultures than in areas whose 
culture doesn't correspond to the western 
model. Obviously, you can't hope for 
informed consent, for example, in the 
case of isolated tribes of Indians,. who 
have no social or ethical criteria that are 
comparable to those of a developed 
society. 
But that doesn't mean there's no patient- 
doctor relationship. 'What should be done 
in these cases? 
It's suggested that one speak to the elders 
of the tribe, but in some cases, 1 think 
even this is premature. 
You've spoken of autonomy and in- 
formed consent. Do you think that, given 
the existente of these two pre-requisites, 
one could justify passive euthanasia? 
On principle, no thinking, sensitive doc- 
tor feels that a patient of his should suf- 
fer. But the concept of suffering is very 
complex. A patient's stay in an intensive 
care unit involves the application of an 
agressive programme of therapeutical 
possibilities. 1 don't doubt that many pa- 
tients, in spite of appearances to the con- 
trary, want,these possibilities to be appli- 
ed to them, want everything possible 
done to save their lives, even if they have 
to suffer severe inconvenience. 1 
sometimes feel that it's the families who 
create the difficulties, more than the pa- 
tients themselves, when it comes to the 
application of high leve1 medical techno- 
logy. Now, there comes a moment when 
it can be said that the balance between 
the benefit, measured in terms of 
therapeutic effectiveness, and the harm, 
taken as the patient's moral suffering, is 
inverted, and comes down heavily on the 
side of the latter. Intolerable abuies have 
been committed in the exaggerated 
treatment of terminal patients. It's what's 
been called therapeutic determination. 1 
think these extremes are unforgivable. 
Even the Pontifical Academy has an- 
nounced that the right to a dignified 
death should be fully recognized. 
But whose responsibility is it to take the 
decision to say 'stop'? 
That's a very difficult question to answer. 
Very often, the doctor obviously doesn't 
te11 the patient he's going to die, because 
he tries to keep his hopes up until the last 
minute. In fact, the doctor is trained and 
prepared to resist and to continue the 
struggle to save his patient's life so long 
as he has the means to do so. 
But ifthe doctor doesn't te11 the patient the 
whole truth about his situation, he is in 
fact taking a unilateral decision. 
If the patient asks, he has to be told the 
truth. Always. And if nothing more can 
be done, some kind of agreement has to 
be reached with the patient. But 1 also 
understand that the doctor should want 
to leave room for hope. It's very difficult 
for him to give up the struggle. 
Sometimes there have been conflicts be- 
tween medical staff and nursing staff, 
because the decision to abandon is far 
from easy. The nursing staff, who gene- 
rally play a very active part in the care of 
the patient and build up a personal rela- 
tionship with him, have sometimes been 
quicker than the families themselves to 
oppose the decision to move a patient out 
of intensive care. Psychologically, this is 
a perfectly understandable reaction, 
because they've made a great effort to 
save the patient's life and al1 that effort is 
lost the moment they give up. 
One of the most hotly debated questions 
as regards health at the moment is the 
distribution of resources. Resources are 
limited and are devoted to certain en& 
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and not to others. What are your feelings 
regarding this problem? 
Until now, no government has managed 
to get on top of medical expenditure. Al1 
cost estimates have been successively ex- 
ceeded because the technology has devel- 
oped according to its own possibilities, 
and has become more and more expen- 
sive. It was thought that the price would 
drop if production was increased, but 
mass production hasn't turned out any 
cheaper. Also, health department budg- 
ets haven't increased at the same rate as 
other activities. As well as this, life ex- 
pectancy has risen in the industrial 
countries and that's made it necessary to 
devote large amounts of technological re- 
sources to the elderly, who are the people 
most in need of medical treatment. In my 
hospital, as in many others, we have 
far more patients of 80 coming in than 
twenty years ago. In those days, it was 
unusual to receive patients of that age. 
And of course, just because they7re 80 
doesn't mean we're going to deny 
them the treatment they'd get if they 
were 60. Besides, generally speaking, 
patients of 80 are in good physical 
shape nowadays and respond well to 
treatment. 
This factor alone can unbalance the 
health budget of any country. But what's - 
also happened over the last few years is 
that there have been great technical ad- 
vances, which allow very expensive oper- 
ations such as transplants. Many of these 
advances have been applied without first 
carrying out a proper cost analysis, which 
makes it difficult afterwards to sum up 
the efficiency of a technique from the 
point of view of costlbenefit, especially if 
it's a technique that's had brilliant re- 
sults, as is the case with transplants. In 
some cases, like kidney transplants, the 
advantages have been clearly demon- 
strated, both in absolute and relative 
terms. It's cheaper to carry out a trans- 
plant than to keep a patient on dialysis. 
On the other hand, in the case of liver 
and heart transplants, the efficiency 
hasn't yet been clearly demonstrated. 
Although 1 think that, sooner or later, 
this will happen. 
Hope is maintained through scientific 
progress itself. Before the discovery of cy- 
closporine, for exam~le, the efficiency of 
transplants was more than doubtful. On 
the other hand, this immuno-suppressor 
has now radically changed the outlook re- 
garding the success of transplants. 
Of course. That7s why it's so difficult to 
apply financia1 criteria to medical pro- 
gress. The discovery of a drug may. be 
enough to reverse the costlbenefit rela- 
tionship of a highly sophisticated tech- 
nique. And very often, the factors in- 
volved have nothing to do with medicine 
itself. For example, faced with the deci- 
sion as to whether or not to authorize a 
particular type of transplant, a gov- 
ernment might find that, as well as the 
rational aspects, it also has to consider 
emotional aspects involved in the deci- 
sion, such as national honour. 
It has been said that the development of 
medical technology leads to un increase in 
the demand for medical treatment. What 
do you feel about this? 
In some ways that can be true. If society 
is offered the possibility of a particular 
course of action, however limited the 
avantages are, it'll be accepted im- 
mediately. Contrary to what a lot of peo- 
ple think, the more doctors a community 
has, the greater the need for medical at- 
tention and the more expensive it is. 
Medical technology hasn't made 
treatment any cheaper, it's simply 
created greater needs. For example, the 
creation of general practice clinics hasn't 
emptied the hospitals. Measures of this 
sort are a great benefit to society, as for 
example, in the early diagnosis of cancer, 
but they don't make medical treatment 
cheaper, which is what we're after. The 
logical thing to do would be to replace 
the technique in use with any improved 
technique that happened to appear. 
What happens in practice is that, instead 
of replacing the old with the new, both 
end up being used at once. Diagnosis 
techniques have got totally out of control 
over the last few years, and very often 
more tests are carried out than is strictly 
necessary. This is also a problem of 
training. Instead of being taught to find 
the correct solution to a problem with the 
minimum of resources, doctors are 
encouraged always to use the maximum 
number of possibilities at their disposal. 
But sometimes, unless al1 the possibilities 
are applied, the patient muy think he's not 
receiving proper treatment. 
The patient sometimes insists on being 
subjected to even the most aggressive 
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techniques, because he understands that 
that way he has more chances of being 
cured. The media have helped to spread 
this idea and to raise medical technology 
to a mythical level. 1 remember when the 
first liver transplant was carried out in 
Barcelona, several relatives of patients 
who were beyond hope came to demand 
that they be given a transplant. Society is 
so used to resorting to technology for 
everything, and if you don't use it, the 
patient starts to think you haven't done 
anything. 
To what extent do you think the prolifer- 
ation of spectacular news stories about 
medical progress conditions patient's 
behaviour? 
Are you referring to the excessive 
medicalization of society? Recently 1 
think the idea of the right to health has 
been driven in very strongly. It's a dan- 
gerous concept be-cause it's demagogic. 
No government has the resources neces- 
sary to guarantee the health of its citi- 
zens. 1 think it would be more reasonable 
to speak of the right not to be ill. 
One of the fields in which, as president of 
the CIOMS, you intend to intervene is that 
of medicines. In what sense? 
What the CIOMS is aiming at, with the 
agreement of the WHO, is the estab- 
lishment of basic treatments that can be 
prescribed al1 over the world. For exam- 
ple, a vaccination or an antiobiotic. It's a 
question of collaborating with the WHO 
in the design of a universally applicable 
formula, of seeing that certain active 
principles can get to every corner of the 
earth. ~ u t  it isn't easy. There are 
countries that can't carry out a vacci- 
nation campaign that would save 
thousands of lives because they haven't 
got a proper cold storage system, and on 
the other hand they've got two hospitals 
with the most sophisticated equipment, 
for example, computerized axial tomo- 
graphy machines. These countries would 
benefit more from having a sewer to 
avoid the spread of typhoid than from 
having a scanner. : 
One of the questions that has caused con- 
troversy recently is that of therapeutic ex- 
perimentation on patients that hadn't been 
informed. What limitations should be 
placed on the doctor when it comes to 
trying out new drugs or surgical tech- 
niques? 
In these cases, there should be absolute 
respect for the principles of autonomy 
and informed consent 1 mentioned earli- 
er. Experimental treatment should in no 
way be carried out on patients who are 
unaware that the product they are being 
given is part of a programme of experi- 
ments. This is something which is quite 
clear. The CIOMS has published a sort of 
code of clinical investigation which 
includes experimental treatment and 
which clearly sets out the guidelines to be 
a followed. First of all, no product can be 
tried on a patient unless it has some 
bearing on his illness. That seems ob- 
vious, but the principie hasn't always 
been respected. Secondly, the patient's 
informed consent should be guaranteed. 
The doctor should explain al1 the pro- 
duct's possible risks to him, bearing in 
mind that they are not always sufficiently 
well known and that it is very difficult to 
provide an explanation that guarantees 
its harmlessness. Third: al1 experimental 
treatment should be administered ac- 
cording to scientific method, with ade- 
quate controls, which involves the 
formation of two groups, one to which 
the experimental product is administered 
and another which receives a placebo or 
other treatment, so as to be able to 
compare the results aftenvards. And a 
product can't be tested unless there is a 
reasonable presumption regarding what 
it is it's going to cure. Also, if the product 
being tested affects an illness for which 
other treatments already exist, the results 
in this case can't be compared against 
those of a placebo but only against those 
of the previously existing product. 
To avoid the superfluous proliferation of 
pharmaceutical products, before authoriz- 
ing the marketing of a new product, some 
countries require proof, not only that it's 
good and efficient, but also that it's 
necessary because it's a substantial im- 
provement on those already on the mar- 
ket. Do you think these criteria should be 
applied everywhere? 
This is a political problem, not an ethical 
one, because at the heart of the question 
is the problem of resources. The labora- 
tories are engaged in full-time economic 
competition. It's very difficult to prove 
that one product's much better than an- 
other, because the differences are usually 
so slight. You must remember that to 
show the validity of a product, it has to be 
tried on a large number of patients, and 
that from the discovery of a new product 
to the day it appears in the chemist's, 
more than ten years have gone by. That is 
to say, it's an extraordinarily expensive 
process. If, once it were over, the pro- 
duct couldn't be marketed because it was 
only marginally beneficial, the laborato- 
ries wouldn't take the risk. 
But there's another thing which 1 find 
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more worrying, and that's the problem of 
the harmful side-effects, which appear 
much later. Let's imagine a harmful side- 
effect that has an incidence of 1 in 
100,000. The medicine has been tried on 
10,000 patients, but the effect, that could 
be serious, won't be detected until the 
product has been administered to more 
than 100,000 people. And another very 
worrying thing is that the safeguards and 
controls applied to medicines aren't also 
applied to medical techniques and appli- 
ances. In the United States these are 
subjected to control, any new appliance 
has to be examined by a team of experts. 
Unfortunately, this control hasn't- 
reached other countries and we come 
across a situation in which appliances that 
aren't authorized in the United States, 
for example, can be freely used in other 
countries, and the same thing happens 
with certain medicines. New inventions 
are constantly appearing that don't man- 
age to pass the test of time, and by the 
time this is shown to be the case, they've 
already done the damage. About twenty 
years ago, for example, a gastric balloon 
appeared that made it possible to freeze 
the stomach and stop a haemorrhage. 
The results of the first tests were thought 
to be extraordinary and were received 
euphorically. Later it was discovered that 
it caused serious gastric injuries and 
the appliance was withdrawn from the 
market. 
In vitro fertilization is a technique which 
the WHO describes as experimental, and 
yet it's used without any control 
whatsoever. Some feminist organizations 
have complained that in these cases 
women are being used as guinea pigs. 
What do you feel about the matter? 
The Catholic Church has issued a direc- 
tive in which it considers that this field of 
science has gone too far. In the last few 
years, progress has been such that there 
hasn't been time to reflect. So far as this 
and many other questions are concerned, 
1 feel that the availability of the technical 
means to do something doesn't necessari- 
ly mean it has to be done. Ability and 
duty are two very different things. 1 think 
this field of investigation shouldn't be left 
to the doctor's free will, but should be 
subjected to a rigorous control imposed 
by society. 
Do you share the concern aroused by ge- 
netic engineering in view of its possible use 
to manipulate man's genetic inheritance? 
The ~oss ibi l i t~  of altering the human ge- 
notype is, in my opinion, simply a matter 
of time. For that reason, the fears are not 
unfounded. And 1 agree with Federico 
Mayor, the new director-general of 
UNESCO, that, above al1 else, we have 
to defend the individual's right to his ge- 
notype. The human being has a right not 
to have his genetic code manipulated. 
Science is now at a crucial stage, that's 
why we're living a period of such un- 
certainty. That's why there's a legal 
vacuum that needs to be filled urgently. 
The only defence society has against this 
problem is legislation. National or supra- 
national legal control. But that doesn't 
offer a complete solution to the problem, 
because no legislation can guarantee that 
there won't be abuses. I've heard conver- 
sations in which a single woman said that 
she'd love to have a son by herself and 
that she'd resort to a sperm bank and ar- 
tificial insemination, which struck me as 
monstruous, because everybody has a 
right to a father and this child won't have 
one, because one woman's selfishness 
can take advantage of medical technolo- 
gy. Technology isn't intrinsically good or 
bad, what's good or bad is the way it's 
used. For example, 1 seriously doubt 
whether it's legitimate that a woman 
who's been waiting ten years for a child 
shouldn't be able to resort to artificial 
insemination from her husband so as to 
be able to have one. The church doesn't 
seem to accept it but 1 feel it difficult to 
forbid. 
You're a Catholic. Do you think the 
Catholic Church is keeping up with the 
times in these matters or is it lagging 
behind? 
The Church can't help being conservative 
and in fact it's tremendously conserva- 
tive. Now, in this question, the Church 
has been sensible enough to express its 
point of view, but without setting out any 
definitive rules. The directive regarding 
artificial insemination is merely intended 
to avoid the abuses that are taking place. 
Do you think it should take a stand or do 
you think it should leave it up to its 
followers? 
1 think it's very difficult to establish limits 
and say "up to here it's moral and from 
here on it's immoral". In such delicate 
situations as this one, the Church chooses 
to say no to everything, because that's ea- 
siest. But 1 think that, in the long run, it's 
time that decides, and what's happened 
on other occasions is that it's set out with 
a radical "no" and has later changed its 
mind. Also, techniques are progressing 
rapidly and while we're thinking about it, 
new possibilities can arise that might 
solve some of the situations we now con- 
sider controversial. W 
